Gilead Sciences Other Investing decreased by 175.0% to -$11.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 68.6%, from -$35.00M to -$11.00M. Over 3 years (FY 2021 to FY 2025), Other Investing shows a downward trend with a -76.9% CAGR.
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
cf_other_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $10.00M | $43.00M | $777.00M | -$776.00M | $2.00M | $5.00M | $1.00M | -$6.00M | $1.00M | -$5.00M | -$7.00M | -$11.00M | -$35.00M | $23.00M | -$10.00M | -$4.00M | -$11.00M |
| QoQ Change | — | -47.4% | +330.0% | >999% | -199.9% | +100.3% | +150.0% | -80.0% | -700.0% | +116.7% | -600.0% | -40.0% | -57.1% | -218.2% | +165.7% | -143.5% | +60.0% | -175.0% |
| YoY Change | — | — | — | — | <-999% | -80.0% | -99.4% | +100.1% | -400.0% | — | -200.0% | -800.0% | -83.3% | <-999% | +560.0% | -42.9% | +63.6% | +68.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.